Active Research Support
Vogelzang is actively involved in many research studies to test new therapies and treatments including:
- A double-blind, randomised, multiplied dose, Phase III, multicentre study of Alpharadin in the treatment of patients with symptomatic hormone refractory prostate cancer with skeletal metastases. The study began in October 2010 and is supported by Algeta USA.
- A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy. The study began in March 2010 and is supported by Cougar Biotechnology.
- A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients with Metastatic Castration-Resistant Prostate Cancer. The study began in April 2009 and is supported by Cougar Biotechnology.
- A Registry of Sipuleucel-T Therapy in men with advanced prostate Cancer. The study began in June 2010 and is supported by Dendreon.
- A Phase 1/2., Open label, dose escalation, selected dose comparison trail of TOK-001 for the Treatment of Chemotherapy naïve castration resistant Prostate Cancer. The study began in September 2009 and is supported by Tokai.
Read more about this topic: Nicholas J. Vogelzang
Famous quotes containing the words active, research and/or support:
“Many writers who choose to be active in the world lose not virtue but time, and that stillness without which literature cannot be made.”
—Gore Vidal (b. 1925)
“After all, the ultimate goal of all research is not objectivity, but truth.”
—Helene Deutsch (1884–1982)
““If only I had a wife!” I used to think, “who could stay home and keep the children happy, why I could support six of them. A cinch.””
—Brenda Ueland (1891–1985)